Promoters of Colistin Resistance in Acinetobacter baumannii Infections

Area of Science:

• Microbiology
• Genetics
• Infectious Diseases

Background:

• Colistin is a critical antibiotic for treating multidrug-resistant Gram-negative bacteria.
• Acinetobacter baumannii is an opportunistic pathogen frequently associated with hospital-acquired infections.
• Mechanisms of colistin resistance in A. baumannii are not fully understood, hindering effective treatment strategies.

Purpose of the Study:

• To elucidate the genetic mechanisms underlying colistin resistance in Acinetobacter baumannii.
• To investigate the role of specific gene mutations (pmrCAB, lpxA, lpxC, lpxD) in conferring resistance.
• To correlate genetic mutations with clinical outcomes and antibiotic susceptibility.

Main Methods:

• Genomic DNA extraction and sequencing of target genes (pmrCAB, lpxA, lpxC, lpxD).
• Gene expression analysis of pmrCAB.
• Detection of carbapenemases and mcr-1 gene.
• Determination of colistin minimum inhibitory concentrations (MICs).

Main Results:

• Mutations in pmrCAB and lpxD genes were frequently observed in colistin-resistant A. baumannii isolates.
• Specific mutations, including I42V and L150F in pmrC, E117K in lpxD, and A138T in pmrB, were associated with significantly higher colistin MICs.
• Co-occurrence of lpxD mutations with pmrCAB mutations suggests a synergistic role in resistance development.
• All isolates harbored the blaOXA-23 gene, indicating carbapenemase production.

Conclusions:

• Mutations in the pmrCAB operon and the lpxD gene are key drivers of colistin resistance in Acinetobacter baumannii.
• The combined presence of these mutations enhances resistance levels and may contribute to treatment failure.
• Understanding these mechanisms is crucial for developing targeted therapies and combating antibiotic resistance.